https://stock.noler.com/us/stock/biolase-inc https://stock.noler.com/us/stock/biolase-inc/accounts-payable https://stock.noler.com/us/stock/biolase-inc/accounts-receivable https://stock.noler.com/us/stock/biolase-inc/accounts-receivable-gross-current https://stock.noler.com/us/stock/biolase-inc/accrued-insurance-current https://stock.noler.com/us/stock/biolase-inc/accrued-liabilities-current https://stock.noler.com/us/stock/biolase-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/biolase-inc/accumulated-depreciation https://stock.noler.com/us/stock/biolase-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/biolase-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/biolase-inc/additional-paid-in-capital https://stock.noler.com/us/stock/biolase-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/biolase-inc/advertising-expense https://stock.noler.com/us/stock/biolase-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/biolase-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/biolase-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/biolase-inc/amended-reports-10-k https://stock.noler.com/us/stock/biolase-inc/amended-reports-10-q https://stock.noler.com/us/stock/biolase-inc/amortization https://stock.noler.com/us/stock/biolase-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/biolase-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/biolase-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/biolase-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/biolase-inc/aoci https://stock.noler.com/us/stock/biolase-inc/asset-acquisition-contingent-consideration-liability https://stock.noler.com/us/stock/biolase-inc/asset-impairment-charges https://stock.noler.com/us/stock/biolase-inc/assets-held-for-sale-current https://stock.noler.com/us/stock/biolase-inc/basic-shares https://stock.noler.com/us/stock/biolase-inc/buybacks-payments-for-repurchase-of-warrants https://stock.noler.com/us/stock/biolase-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/biolase-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/biolase-inc/capital-expenditures https://stock.noler.com/us/stock/biolase-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/biolase-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/biolase-inc/capital-lease-obligations-incurred https://stock.noler.com/us/stock/biolase-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/biolase-inc/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/biolase-inc/capital-leases-future-minimum-payments-due-in-rolling-year-three https://stock.noler.com/us/stock/biolase-inc/capital-leases-future-minimum-payments-due-in-rolling-year-two https://stock.noler.com/us/stock/biolase-inc/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/biolase-inc/capital-leases-future-minimum-payments-present-value-of-net-minimum-payments https://stock.noler.com/us/stock/biolase-inc/capital-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/biolase-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/biolase-inc/cash-and-equivalents https://stock.noler.com/us/stock/biolase-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/biolase-inc/cash-flow-breakdown https://stock.noler.com/us/stock/biolase-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/biolase-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/biolase-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/biolase-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/biolase-inc/clinical-trials https://stock.noler.com/us/stock/biolase-inc/common-stock-dividends-shares https://stock.noler.com/us/stock/biolase-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/biolase-inc/common-stock-value https://stock.noler.com/us/stock/biolase-inc/comprehensive-income https://stock.noler.com/us/stock/biolase-inc/concentration-risk-percentage https://stock.noler.com/us/stock/biolase-inc/contract-liability https://stock.noler.com/us/stock/biolase-inc/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/biolase-inc/contractual-obligation https://stock.noler.com/us/stock/biolase-inc/contractual-obligation-due-in-fourth-year https://stock.noler.com/us/stock/biolase-inc/contractual-obligation-due-in-second-year https://stock.noler.com/us/stock/biolase-inc/contractual-obligation-due-in-third-year https://stock.noler.com/us/stock/biolase-inc/contractual-obligation-future-minimum-payments-due-remainder-of-fiscal-year https://stock.noler.com/us/stock/biolase-inc/cost-of-goods-sold https://stock.noler.com/us/stock/biolase-inc/cost-of-goods-sold-depreciation-depletion-and-amortization https://stock.noler.com/us/stock/biolase-inc/cost-of-revenue https://stock.noler.com/us/stock/biolase-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/biolase-inc/current-assets https://stock.noler.com/us/stock/biolase-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/biolase-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/biolase-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/biolase-inc/current-liabilities https://stock.noler.com/us/stock/biolase-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/biolase-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/biolase-inc/customer-deposits-current https://stock.noler.com/us/stock/biolase-inc/debt-carrying-amount https://stock.noler.com/us/stock/biolase-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/biolase-inc/debt-decrease-forgiveness https://stock.noler.com/us/stock/biolase-inc/debt-fee-amount https://stock.noler.com/us/stock/biolase-inc/debt-interest-rate-increase-decrease https://stock.noler.com/us/stock/biolase-inc/debt-issuance-costs https://stock.noler.com/us/stock/biolase-inc/debt-issued https://stock.noler.com/us/stock/biolase-inc/debt-maturing-after-year-five https://stock.noler.com/us/stock/biolase-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/biolase-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/biolase-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/biolase-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/biolase-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/biolase-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/biolase-inc/debt-related-commitment-fees-and-debt-issuance-costs https://stock.noler.com/us/stock/biolase-inc/debt-repaid https://stock.noler.com/us/stock/biolase-inc/debt-securities-unrealized-gain-loss https://stock.noler.com/us/stock/biolase-inc/debt-unamortized-discount-premium-and-debt-issuance-costs-net https://stock.noler.com/us/stock/biolase-inc/debt-weighted-average-interest-rate https://stock.noler.com/us/stock/biolase-inc/deferred-compensation-share-based-arrangements-liability-current https://stock.noler.com/us/stock/biolase-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/biolase-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/biolase-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/biolase-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/biolase-inc/deferred-revenue https://stock.noler.com/us/stock/biolase-inc/deferred-revenue-2 https://stock.noler.com/us/stock/biolase-inc/deferred-revenue-additions https://stock.noler.com/us/stock/biolase-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/biolase-inc/deferred-revenue-revenue-recognized https://stock.noler.com/us/stock/biolase-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/biolase-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/biolase-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/biolase-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/biolase-inc/deferred-tax-assets-inventory https://stock.noler.com/us/stock/biolase-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/biolase-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/biolase-inc/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/biolase-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/biolase-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/biolase-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/biolase-inc/deferred-tax-assets-other-comprehensive-loss https://stock.noler.com/us/stock/biolase-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/biolase-inc/deferred-tax-assets-state-taxes https://stock.noler.com/us/stock/biolase-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/biolase-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/biolase-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-loss-reserves https://stock.noler.com/us/stock/biolase-inc/deferred-tax-assets-unrealized-currency-losses https://stock.noler.com/us/stock/biolase-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/biolase-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/biolase-inc/deferred-tax-liabilities-deferred-expense https://stock.noler.com/us/stock/biolase-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-goodwill https://stock.noler.com/us/stock/biolase-inc/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/biolase-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/biolase-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/biolase-inc/depreciation https://stock.noler.com/us/stock/biolase-inc/depreciation-and-amortization https://stock.noler.com/us/stock/biolase-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/biolase-inc/diluted-shares https://stock.noler.com/us/stock/biolase-inc/disposal-group-not-discontinued-operation-gain-loss-on-disposal https://stock.noler.com/us/stock/biolase-inc/dividends-declared https://stock.noler.com/us/stock/biolase-inc/dividends-preferred-stock-stock https://stock.noler.com/us/stock/biolase-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/biolase-inc/effective-tax-rate https://stock.noler.com/us/stock/biolase-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/biolase-inc/entity-wide-revenue-major-customer-percentage https://stock.noler.com/us/stock/biolase-inc/eps https://stock.noler.com/us/stock/biolase-inc/eps-basic https://stock.noler.com/us/stock/biolase-inc/equity-method-investment-quoted-market-value https://stock.noler.com/us/stock/biolase-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/biolase-inc/extended-product-warranty-accrual https://stock.noler.com/us/stock/biolase-inc/extended-product-warranty-accrual-current https://stock.noler.com/us/stock/biolase-inc/extended-product-warranty-accrual-noncurrent https://stock.noler.com/us/stock/biolase-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/biolase-inc/fair-value-assumptions-expected-dividend-payments https://stock.noler.com/us/stock/biolase-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/biolase-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/biolase-inc/fair-value-concentration-of-risk-accounts-receivable https://stock.noler.com/us/stock/biolase-inc/fair-value-inputs-discount-rate https://stock.noler.com/us/stock/biolase-inc/fair-value-investments-entities-that-calculate-net-asset-value-per-share-percent-equity-securities https://stock.noler.com/us/stock/biolase-inc/financing-cash-flow https://stock.noler.com/us/stock/biolase-inc/financing-interest-expense https://stock.noler.com/us/stock/biolase-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/biolase-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/biolase-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/biolase-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/biolase-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/biolase-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/biolase-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/biolase-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/biolase-inc/foreign-earnings https://stock.noler.com/us/stock/biolase-inc/form-d-other https://stock.noler.com/us/stock/biolase-inc/form-d-stocks https://stock.noler.com/us/stock/biolase-inc/gain-loss-on-disposition-of-intangible-assets https://stock.noler.com/us/stock/biolase-inc/gain-loss-on-sale-of-other-assets https://stock.noler.com/us/stock/biolase-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/biolase-inc/gain-loss-related-to-litigation-settlement https://stock.noler.com/us/stock/biolase-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/biolase-inc/general-and-administrative-expense https://stock.noler.com/us/stock/biolase-inc/geographic-long-lived-assets-in-foreign-countries https://stock.noler.com/us/stock/biolase-inc/goodwill https://stock.noler.com/us/stock/biolase-inc/goodwill-and-intangible-asset-impairment https://stock.noler.com/us/stock/biolase-inc/goodwill-gross https://stock.noler.com/us/stock/biolase-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/biolase-inc/gross-profit https://stock.noler.com/us/stock/biolase-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/biolase-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/biolase-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/biolase-inc/income-loss-from https://stock.noler.com/us/stock/biolase-inc/income-tax https://stock.noler.com/us/stock/biolase-inc/income-taxes-paid https://stock.noler.com/us/stock/biolase-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/biolase-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/biolase-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/biolase-inc/increase-decrease-in-customer-deposits https://stock.noler.com/us/stock/biolase-inc/increase-decrease-in-deferred-compensation https://stock.noler.com/us/stock/biolase-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/biolase-inc/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/biolase-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/biolase-inc/increase-decrease-in-operating-assets https://stock.noler.com/us/stock/biolase-inc/increase-decrease-in-other-operating-capital-net https://stock.noler.com/us/stock/biolase-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/biolase-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/biolase-inc/insider-transactions-other https://stock.noler.com/us/stock/biolase-inc/insider-transactions-preferred https://stock.noler.com/us/stock/biolase-inc/insider-transactions-preferred/purchases https://stock.noler.com/us/stock/biolase-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/biolase-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/biolase-inc/insider-transactions-warrants https://stock.noler.com/us/stock/biolase-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/biolase-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/biolase-inc/interest-and-debt-expense https://stock.noler.com/us/stock/biolase-inc/interest-expense https://stock.noler.com/us/stock/biolase-inc/interest-expense-borrowings https://stock.noler.com/us/stock/biolase-inc/interest-expense-on-debt https://stock.noler.com/us/stock/biolase-inc/interest-expense-other https://stock.noler.com/us/stock/biolase-inc/interest-expense-related-party https://stock.noler.com/us/stock/biolase-inc/interest-income-expense-net https://stock.noler.com/us/stock/biolase-inc/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/biolase-inc/interest-paid https://stock.noler.com/us/stock/biolase-inc/interest-paid-net https://stock.noler.com/us/stock/biolase-inc/interest-payable-current https://stock.noler.com/us/stock/biolase-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/biolase-inc/inventory https://stock.noler.com/us/stock/biolase-inc/inventory-finished-goods https://stock.noler.com/us/stock/biolase-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/biolase-inc/inventory-raw-materials https://stock.noler.com/us/stock/biolase-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/biolase-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/biolase-inc/inventory-work-in-process https://stock.noler.com/us/stock/biolase-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/biolase-inc/inventory-write-down https://stock.noler.com/us/stock/biolase-inc/investing-cash-flow https://stock.noler.com/us/stock/biolase-inc/investment-income-interest https://stock.noler.com/us/stock/biolase-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/biolase-inc/labor-and-related-expense https://stock.noler.com/us/stock/biolase-inc/land https://stock.noler.com/us/stock/biolase-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/biolase-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/biolase-inc/lease-and-rental-expense https://stock.noler.com/us/stock/biolase-inc/legal-fees https://stock.noler.com/us/stock/biolase-inc/lessee-operating-lease-discount-rate https://stock.noler.com/us/stock/biolase-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/biolase-inc/licenses-revenue https://stock.noler.com/us/stock/biolase-inc/line-of-credit https://stock.noler.com/us/stock/biolase-inc/line-of-credit-facility-amount-outstanding https://stock.noler.com/us/stock/biolase-inc/line-of-credit-facility-commitment-fee-amount https://stock.noler.com/us/stock/biolase-inc/line-of-credit-facility-fair-value-of-amount-outstanding https://stock.noler.com/us/stock/biolase-inc/line-of-credit-facility-increase-accrued-interest https://stock.noler.com/us/stock/biolase-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/biolase-inc/line-of-credit-facility-remaining-borrowing-capacity https://stock.noler.com/us/stock/biolase-inc/line-of-credit-facility-unused-capacity-commitment-fee-percentage https://stock.noler.com/us/stock/biolase-inc/lines-of-credit-current https://stock.noler.com/us/stock/biolase-inc/litigation-reserve https://stock.noler.com/us/stock/biolase-inc/litigation-settlement-amount https://stock.noler.com/us/stock/biolase-inc/loans-payable-current https://stock.noler.com/us/stock/biolase-inc/long-term-debt https://stock.noler.com/us/stock/biolase-inc/long-term-debt-percentage-bearing-fixed-interest-rate https://stock.noler.com/us/stock/biolase-inc/long-term-loans-payable https://stock.noler.com/us/stock/biolase-inc/mediumterm-notes-current https://stock.noler.com/us/stock/biolase-inc/mediumterm-notes-noncurrent https://stock.noler.com/us/stock/biolase-inc/money-market-funds-at-carrying-value https://stock.noler.com/us/stock/biolase-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/biolase-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/biolase-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/biolase-inc/net-change-in-cash https://stock.noler.com/us/stock/biolase-inc/net-income https://stock.noler.com/us/stock/biolase-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/biolase-inc/noncash-or-part-noncash-acquisition-intangible-assets-acquired https://stock.noler.com/us/stock/biolase-inc/number-of-operating-segments https://stock.noler.com/us/stock/biolase-inc/number-of-reportable-segments https://stock.noler.com/us/stock/biolase-inc/number-of-reporting-units https://stock.noler.com/us/stock/biolase-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/biolase-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/biolase-inc/operating-cash-flow https://stock.noler.com/us/stock/biolase-inc/operating-expenses https://stock.noler.com/us/stock/biolase-inc/operating-income https://stock.noler.com/us/stock/biolase-inc/operating-lease-assets https://stock.noler.com/us/stock/biolase-inc/operating-lease-liability https://stock.noler.com/us/stock/biolase-inc/operating-lease-liability-current https://stock.noler.com/us/stock/biolase-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/biolase-inc/operating-lease-payments https://stock.noler.com/us/stock/biolase-inc/operating-lease-payments-due https://stock.noler.com/us/stock/biolase-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/biolase-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/biolase-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/biolase-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/biolase-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/biolase-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/biolase-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/biolase-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/biolase-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/biolase-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/biolase-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/biolase-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/biolase-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/biolase-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/biolase-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/biolase-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/biolase-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/biolase-inc/other-current-assets https://stock.noler.com/us/stock/biolase-inc/other-income https://stock.noler.com/us/stock/biolase-inc/other-income-2 https://stock.noler.com/us/stock/biolase-inc/other-noncash-expense https://stock.noler.com/us/stock/biolase-inc/other-noncash-income-expense https://stock.noler.com/us/stock/biolase-inc/other-noncurrent-assets https://stock.noler.com/us/stock/biolase-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/biolase-inc/other-nonoperating-gains-losses https://stock.noler.com/us/stock/biolase-inc/other-receivables-net-current https://stock.noler.com/us/stock/biolase-inc/paid-in-capital-share-based-compensation-other-longterm-incentive-plans-requisite-service-period-recognition https://stock.noler.com/us/stock/biolase-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/biolase-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/biolase-inc/paid-in-capital-stock-split https://stock.noler.com/us/stock/biolase-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/biolase-inc/patents-active https://stock.noler.com/us/stock/biolase-inc/patents-pending https://stock.noler.com/us/stock/biolase-inc/patents-rejected https://stock.noler.com/us/stock/biolase-inc/payments-for-legal-settlements https://stock.noler.com/us/stock/biolase-inc/payments-for-rent https://stock.noler.com/us/stock/biolase-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/biolase-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/biolase-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/biolase-inc/policyholder-dividends-rate-on-policy-earnings https://stock.noler.com/us/stock/biolase-inc/preferred-shares-facts https://stock.noler.com/us/stock/biolase-inc/preferred-stock-dividend-rate-percentage https://stock.noler.com/us/stock/biolase-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/biolase-inc/preferred-stock-redemption-amount-future-redeemable-securities https://stock.noler.com/us/stock/biolase-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/biolase-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/biolase-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/biolase-inc/preferred-stock-value https://stock.noler.com/us/stock/biolase-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/biolase-inc/prepaid-insurance https://stock.noler.com/us/stock/biolase-inc/pretax-income https://stock.noler.com/us/stock/biolase-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/biolase-inc/proceeds-from-interest-received https://stock.noler.com/us/stock/biolase-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/biolase-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/biolase-inc/proceeds-from-issuance-of-other-long-term-debt https://stock.noler.com/us/stock/biolase-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/biolase-inc/proceeds-from-issuance-of-preferred-stock-preference-stock-and-warrants https://stock.noler.com/us/stock/biolase-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/biolase-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/biolase-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/biolase-inc/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/biolase-inc/proceeds-from-long-term-lines-of-credit https://stock.noler.com/us/stock/biolase-inc/proceeds-from-other-equity https://stock.noler.com/us/stock/biolase-inc/proceeds-from-repayments-of-restricted-cash-financing-activities https://stock.noler.com/us/stock/biolase-inc/proceeds-from-sale-of-productive-assets https://stock.noler.com/us/stock/biolase-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/biolase-inc/proceeds-from-sale-of-treasury-stock https://stock.noler.com/us/stock/biolase-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/biolase-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/biolase-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/biolase-inc/product-warranty-accrual https://stock.noler.com/us/stock/biolase-inc/product-warranty-accrual-classified-current https://stock.noler.com/us/stock/biolase-inc/product-warranty-accrual-noncurrent https://stock.noler.com/us/stock/biolase-inc/product-warranty-accrual-payments https://stock.noler.com/us/stock/biolase-inc/product-warranty-accrual-preexisting-increase-decrease https://stock.noler.com/us/stock/biolase-inc/product-warranty-accrual-warranties-issued https://stock.noler.com/us/stock/biolase-inc/product-warranty-expense https://stock.noler.com/us/stock/biolase-inc/profit-loss https://stock.noler.com/us/stock/biolase-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/biolase-inc/property-plant-and-equipment-gross-change https://stock.noler.com/us/stock/biolase-inc/property-plant-equipment https://stock.noler.com/us/stock/biolase-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/biolase-inc/provision-for-loan-lease-and-other-losses https://stock.noler.com/us/stock/biolase-inc/public-float https://stock.noler.com/us/stock/biolase-inc/purchase-obligations-balance-sheet-amount https://stock.noler.com/us/stock/biolase-inc/repayments-of-debt https://stock.noler.com/us/stock/biolase-inc/repayments-of-debt-and-capital-lease-obligations https://stock.noler.com/us/stock/biolase-inc/repayments-of-lines-of-credit https://stock.noler.com/us/stock/biolase-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/biolase-inc/repayments-of-long-term-lines-of-credit https://stock.noler.com/us/stock/biolase-inc/research-and-development https://stock.noler.com/us/stock/biolase-inc/restricted-cash https://stock.noler.com/us/stock/biolase-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/biolase-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/biolase-inc/retained-earnings https://stock.noler.com/us/stock/biolase-inc/revenue https://stock.noler.com/us/stock/biolase-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/biolase-inc/royalty-revenue https://stock.noler.com/us/stock/biolase-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/biolase-inc/sales-and-excise-tax-payable-current https://stock.noler.com/us/stock/biolase-inc/sales-returns-and-allowances-goods https://stock.noler.com/us/stock/biolase-inc/sales-revenue-net https://stock.noler.com/us/stock/biolase-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/biolase-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/biolase-inc/sec-filings-10-k https://stock.noler.com/us/stock/biolase-inc/sec-filings-10-k405 https://stock.noler.com/us/stock/biolase-inc/sec-filings-10-q https://stock.noler.com/us/stock/biolase-inc/sec-filings-10ksb https://stock.noler.com/us/stock/biolase-inc/sec-filings-10qsb https://stock.noler.com/us/stock/biolase-inc/sec-filings-25-nse https://stock.noler.com/us/stock/biolase-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/biolase-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/biolase-inc/sec-filings-8-k https://stock.noler.com/us/stock/biolase-inc/sec-filings-ars https://stock.noler.com/us/stock/biolase-inc/sec-filings-ct-order https://stock.noler.com/us/stock/biolase-inc/sec-filings-def-14a https://stock.noler.com/us/stock/biolase-inc/sec-filings-defa14a https://stock.noler.com/us/stock/biolase-inc/sec-filings-defc14a https://stock.noler.com/us/stock/biolase-inc/sec-filings-defr14a https://stock.noler.com/us/stock/biolase-inc/sec-filings-dfan14a https://stock.noler.com/us/stock/biolase-inc/sec-filings-ntn-10q https://stock.noler.com/us/stock/biolase-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/biolase-inc/sec-filings-prec14a https://stock.noler.com/us/stock/biolase-inc/sec-filings-prer14a https://stock.noler.com/us/stock/biolase-inc/sec-filings-regdex https://stock.noler.com/us/stock/biolase-inc/sec-filings-sd https://stock.noler.com/us/stock/biolase-inc/sec-filings-sec-staff-action https://stock.noler.com/us/stock/biolase-inc/secondary-offerings-form-424b1 https://stock.noler.com/us/stock/biolase-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/biolase-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/biolase-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/biolase-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/biolase-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/biolase-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/biolase-inc/secondary-offerings-form-pos-ex https://stock.noler.com/us/stock/biolase-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/biolase-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/biolase-inc/secondary-offerings-form-s-1mef https://stock.noler.com/us/stock/biolase-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/biolase-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/biolase-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/biolase-inc/settlement-liabilities-current https://stock.noler.com/us/stock/biolase-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-average-exercise-price https://stock.noler.com/us/stock/biolase-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/biolase-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/biolase-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-outstanding-options-average-exercise-price-beginning-balance https://stock.noler.com/us/stock/biolase-inc/share-based-goods-and-nonemployee-services-transaction-expense https://stock.noler.com/us/stock/biolase-inc/shareholders-equity https://stock.noler.com/us/stock/biolase-inc/shares-authorized https://stock.noler.com/us/stock/biolase-inc/shares-issued https://stock.noler.com/us/stock/biolase-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/biolase-inc/short-term-bank-loans-and-notes-payable https://stock.noler.com/us/stock/biolase-inc/standard-product-warranty-accrual https://stock.noler.com/us/stock/biolase-inc/standard-product-warranty-accrual-current https://stock.noler.com/us/stock/biolase-inc/standard-product-warranty-accrual-payments https://stock.noler.com/us/stock/biolase-inc/standard-product-warranty-accrual-warranties-issued https://stock.noler.com/us/stock/biolase-inc/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/biolase-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/biolase-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/biolase-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/biolase-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/biolase-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/biolase-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/biolase-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/biolase-inc/stock-based-compensation https://stock.noler.com/us/stock/biolase-inc/stock-compensation-tax-benefit-realized-from-exercise-of-stock-options https://stock.noler.com/us/stock/biolase-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/biolase-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/biolase-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/biolase-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/biolase-inc/stock-issued-shares-issued-shares-reverse-stock-splits https://stock.noler.com/us/stock/biolase-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/biolase-inc/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/biolase-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/biolase-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/biolase-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/biolase-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/biolase-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/biolase-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/biolase-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/biolase-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/biolase-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/biolase-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/biolase-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/biolase-inc/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/biolase-inc/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/biolase-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/biolase-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/biolase-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/biolase-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/biolase-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/biolase-inc/stock-options-vested-in-period-fair-value-1 https://stock.noler.com/us/stock/biolase-inc/stock-repurchase-program-number-of-shares-authorized-to-be-repurchased https://stock.noler.com/us/stock/biolase-inc/stock-split-ratio https://stock.noler.com/us/stock/biolase-inc/stockholders-equity-before-treasury-stock https://stock.noler.com/us/stock/biolase-inc/supplemental-unemployment-benefits-severance-benefits https://stock.noler.com/us/stock/biolase-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/biolase-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/biolase-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/biolase-inc/tax-rate-reconciliation-deductions-other https://stock.noler.com/us/stock/biolase-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/biolase-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/biolase-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/biolase-inc/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/biolase-inc/tax-rate-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/biolase-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/biolase-inc/tax-rate-reconciliation-tax-credits-other https://stock.noler.com/us/stock/biolase-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/biolase-inc/tax-reconciliation-tax-credits https://stock.noler.com/us/stock/biolase-inc/taxes-payable-current https://stock.noler.com/us/stock/biolase-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/biolase-inc/temporary-equity-dividends-adjustment https://stock.noler.com/us/stock/biolase-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/biolase-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/biolase-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/biolase-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/biolase-inc/total-assets https://stock.noler.com/us/stock/biolase-inc/total-contract-liability https://stock.noler.com/us/stock/biolase-inc/total-liabilities https://stock.noler.com/us/stock/biolase-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/biolase-inc/total-long-term-debt https://stock.noler.com/us/stock/biolase-inc/treasury-shares-acquired https://stock.noler.com/us/stock/biolase-inc/treasury-stock-acquired-average-cost-per-share https://stock.noler.com/us/stock/biolase-inc/treasury-stock-shares https://stock.noler.com/us/stock/biolase-inc/treasury-stock-shares-retired https://stock.noler.com/us/stock/biolase-inc/treasury-stock-value https://stock.noler.com/us/stock/biolase-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/biolase-inc/utb-change https://stock.noler.com/us/stock/biolase-inc/utb-income-tax-penalties-accrued https://stock.noler.com/us/stock/biolase-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/biolase-inc/utb-interest-on-income-taxes-accrued https://stock.noler.com/us/stock/biolase-inc/utb-reduction-from-statute-lapse https://stock.noler.com/us/stock/biolase-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/biolase-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/biolase-inc/weighted-average-number-of-share-outstanding-basic-and-diluted